| pubmed-article:12077596 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12077596 | lifeskim:mentions | umls-concept:C0026948 | lld:lifeskim |
| pubmed-article:12077596 | lifeskim:mentions | umls-concept:C0677874 | lld:lifeskim |
| pubmed-article:12077596 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:12077596 | lifeskim:mentions | umls-concept:C1705576 | lld:lifeskim |
| pubmed-article:12077596 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:12077596 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:12077596 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12077596 | pubmed:dateCreated | 2002-6-21 | lld:pubmed |
| pubmed-article:12077596 | pubmed:abstractText | Advanced mycosis fungoides (MF) is incurable with conventional treatments. High-dose chemoradiotherapy with autologous bone marrow transplantation has induced remissions in a small number of patients with MF, but this modality is limited by a high relapse rate. We report induction of complete remission in a 37-year-old woman with rapidly progressive stage IV MF with allogeneic stem cell transplantation (Allo SCT). She remains in continuous complete remission 2 years after transplant. Allo SCT for MF is theoretically attractive, because there is no contamination of the graft by malignant cells, and because of the possibility of graft-versus-tumor effect. Although the results in this patient are encouraging, more patients and longer follow-up are needed to define the usefulness of Allo SCT in the treatment of MF. | lld:pubmed |
| pubmed-article:12077596 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12077596 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12077596 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12077596 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12077596 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:12077596 | pubmed:issn | 0190-9622 | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:FeferAlexande... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:SaleGeorge... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:FlowersMary... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:SabathDaniel... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:ThompsonJohn... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:MasoodNehalN | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:RussellKennet... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:OlerudJohn... | lld:pubmed |
| pubmed-article:12077596 | pubmed:author | pubmed-author:DoneyKristine... | lld:pubmed |
| pubmed-article:12077596 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12077596 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:12077596 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12077596 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12077596 | pubmed:pagination | 140-5 | lld:pubmed |
| pubmed-article:12077596 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:meshHeading | pubmed-meshheading:12077596... | lld:pubmed |
| pubmed-article:12077596 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12077596 | pubmed:articleTitle | Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation. | lld:pubmed |
| pubmed-article:12077596 | pubmed:affiliation | Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA 98109-1023, USA. | lld:pubmed |
| pubmed-article:12077596 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12077596 | pubmed:publicationType | Case Reports | lld:pubmed |
| pubmed-article:12077596 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
